IP Library Granted Patent US 11,771,835
Granted Patent B2
US 11,771,835 · App. 17/303,748 · Granted Oct 3, 2023

Therapy assist information and/or tracking device and related methods and systems

Inventors: John Sjolund (Los Altos, CA); Ambika Srinath (San Francisco, CA); Andrew Bochenko (Redwood City, CA); George Crothall (Oceanside, CA); Bryan Mazlish (Palo Alto, CA); Lane Desborough (Thousand Oaks, CA); Jennifer Martin Block (Menlo Park, CA); Sarah Matarese (San Jose, CA); Linda Mackowiak (Cazenovia, NY)
Assignee: Bigfoot Biomedical, Inc.
A61M5/31546A61B5/0004A61B5/14532A61B5/4836A61B5/4839A61B5/7405A61B5/746A61B5/7435A61B5/7455A61K38/28A61M5/003A61M5/168A61M5/20A61M5/31525A61M5/3202G16H20/13G16H20/17G16H20/60G16H40/63G16H40/67G16H50/20G16H50/30A61B5/14546A61B5/681A61M5/24A61M2005/14208A61M2005/2006A61M2005/3125A61M2205/18A61M2205/3306A61M2205/3561A61M2205/3584A61M2205/502A61M2205/505A61M2205/581A61M2205/582A61M2205/583A61M2209/06A61M2230/201
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,771,835
App. No.
17/303,748
Granted
Oct 3, 2023
Kind
B2
Abstract

A monitoring feature, such as, for example, a pen cap, for an insulin delivery device may include at least one circuit adapted to detect at least one of a capping or decapping of the pen cap from an insulin pen and a processor for using information to the at least one of a capping or decapping of the pen cap. A monitoring feature for an insulin delivery device includes at least one circuit adapted to detect use of the insulin delivery device.

Claims (43)

1. A pen cap for an insulin pen comprising:

at least one user interface to display at least one of therapy relevant information, therapy recommendations, or a time of the at least one of a capping or decapping of the pen cap;

a controller comprising:

at least one processor; and

at least one non-transitory computer-readable storage medium storing instructions thereon that, when executed by the at least one processor, cause the controller to:

detect at least one of a capping or decapping of the pen cap from an insulin pen; and

responsive to the pen cap being capped on the insulin pen for a threshold period of time, cause the at least one user interface to display a recommended correction dose of insulin based at least partially on an insulin sensitivity factor and a target glucose value.

2. The pen cap of claim 1 , further comprising instructions that, when executed by the at least one processor, cause the controller to: receive glucose data.

3. The pen cap of claim 1 , wherein the pen cap is configured to be utilized with one of a long-acting insulin pen or a rapid-acting insulin pen.

4. The pen cap of claim 1 , further comprising instructions that, when executed by the at least one processor, cause the controller to: cause a communication interface of the pen cap to generate a fist wireless signal and a second wireless signal, wherein the second wireless signal has a communication range that is larger than communication range of the first wireless signal.

5. The pen cap of claim 4 , wherein the first wireless signal is configured for communication with a glucose monitor when the glucose monitor is positioned within the communication range of the first wireless signal of the pen cap.

6. The pen cap of claim 4 , wherein the second wireless signal is configured to communicate with at least one of a glucose monitor or another remote device.

7. The pen cap of claim 4 , further comprising instructions that, when executed by the at least one processor, cause the controller to: automatically communicate with at least one of a glucose monitor or another remote device via the second wireless signal.

8. The pen cap of claim 4 , wherein the communication interface comprises at least one wireless radio.

9. The pen cap of claim 4 , further comprising instructions that, when executed by the at least one processor, cause the controller to:

detect a glucose monitor within the communication range of the first wireless signal of the pen cap; and

cause the communication interface to communicate with the glucose monitor via a near field communication protocol.

10. The pen cap of claim 4 , further comprising instructions that, when executed by the at least one processor, cause the controller to:

cause the communication interface to communicate with a glucose monitor via a first communication protocol; and

cause the communication interface to communicate with a mobile computing device via a second, different communication protocol.

11. The pen cap of claim 1 , further comprising instructions that, when executed by the at least one processor, cause the controller to: communicate with a glucose sensor system comprising a flash glucose monitor.

12. The pen cap of claim 1 , further comprising instructions that, when executed by the at least one processor, cause the controller to: cause the at least one user interface to display a representation of a percentage of active insulin remaining within a user based on a time of a previous capping or decapping of the pen cap and a current time.

13. The pen cap of claim 12 , further comprising instructions that, when executed by the at least one processor, cause the controller to:

determine an amount of insulin remaining in the insulin pen;

determine a dose amount and time associated within a previous capping or decapping of the pen cap; and

cause the at least one user interface to display an estimation of active insulin remaining within the user based a current time and the time and dose amount associated with the previous capping or decapping of the pen cap.

14. A pen cap for an insulin delivery device comprising:

at least one user interface to display at least one of therapy relevant information, therapy recommendations, or a time of the at least one of a capping or decapping of the pen cap; and

a controller comprising:

at least one processor; and

at least one non-transitory computer-readable storage medium storing instructions thereon that, when executed by the at least one processor, cause the pen cap to:

detect motion of the pen cap; and

responsive to the pen cap being motionless for at least a threshold period of time, cause the at least one user interface to display a recommended correction dose of insulin based at least partially on an insulin sensitivity factor and a target glucose value stored in memory.

15. The pen cap of claim 14 , further comprising instructions that, when executed by the at least one processor, cause the controller to: receive glucose data from a blood glucose monitor.

16. The pen cap of claim 14 , further comprising instructions that, when executed by the at least one processor, cause the controller to: cause a communication interface of the pen cap to generate a fist wireless signal and a second wireless signal, wherein the second wireless signal has a communication range that is larger than communication range of the first wireless signal.

17. The pen cap of claim 16 , wherein the first wireless signal is configured for communication with a glucose monitor when the glucose monitor is positioned within the communication range of the first wireless signal of the pen cap.

18. The pen cap of claim 16 , further comprising instructions that, when executed by the at least one processor, cause the controller to:

cause the communication interface to communicate with a glucose monitor via a first communication protocol; and

cause the communication interface to communicate with a mobile computing device via a second, different communication protocol.

19. A method of delivering insulin, comprising:

detecting at least one of a capping or decapping of a pen cap from an insulin pen; and

responsive to the pen cap being capped on the insulin pen for a threshold period of time, displaying a recommended correction dose of insulin based at least partially on an insulin sensitivity factor and a target glucose value.

20. The method of claim 19 , further comprising, responsive to the pen cap being motionless for at least a threshold period of time, displaying a recommended correction dose of insulin.

Assignments (4)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 23, 2024
From: SJOLUND, JOHN; SRINATH, AMBIKA; BOCHENKO, ANDREW; CROTHALL, GEORGE; MAZLISH, BRYAN; DESBOROUGH, LANE; BLOCK, JENNIFER MARTIN; MATARESE, SARAH; MACKOWIAK, LINDA
To: BIGFOOT BIOMEDICAL, INC.
Reel/Frame 068660/0277 →
SECURITY INTEREST Recorded Sep 23, 2024
From: BIGFOOT BIOMEDICAL, INC.
To: MADRYN HEALTH PARTNERS, LP
Reel/Frame 069019/0142 →
SECURITY INTEREST Recorded Sep 23, 2024
From: MADRYN HEALTH PARTNERS, LP
To: MADRYN FUND ADMINISTRATION, LLC
Reel/Frame 069019/0188 →
RELEASE OF SECURITY INTEREST Recorded Sep 23, 2024
From: MADRYN FUND ADMINISTRATION, LLC
To: BIGFOOT BIOMEDICAL, INC.
Reel/Frame 069019/0346 →
Continuity (3)
Continuation 16218026 · Dec 12, 2018
Provisional Application 62597868 · Dec 12, 2017
Related Publication 20210290853A1 · Sep 23, 2021
Cited By (3)
US 12,207,952 US 12,616,426 US 12,629,106